Showing results (491-500 of 844) with videos related to

Sort By:
Pageof 85
Clinical Breast Cancer|March 1, 2018
Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast CancerAntonella Palazzo, Silvia Dellapasqua, Elisabetta Munzone, et al.
Cell Death & Disease|November 11, 2016
Reed-Sternberg cells in Hodgkin's lymphoma present features of cellular senescenceJ Gopas, E Stern, U Zurgil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burdenF Nolè, F de Braud, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group)V Spataro, K Price, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapiesM Colleoni, N Rotmensz, G Peruzzotti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1993
The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG)C Hürny, J Bernhard, M Bacchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Marco Colleoni, Shari Gelber, et al.
Clinical Breast Cancer|December 15, 2010
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancerRosalba Torrisi, Anna Cardillo, Giuseppe Cancello, et al.
Breast Cancer Research and Treatment|January 12, 2011
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancerRosalba Torrisi, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combinationC Catania, M Medici, E Magni, et al.
Pageof 85